WoundScribe AI
Share
X Facebook WhatsApp Email

Inside the Healing Trajectory Agent: How WoundScribe Predicts Stalled Wounds

product

Published

A deep dive into the healing analytics agent that reads every wound over time and flags stalling before you lose three visits.

Most EMRs document what happened. The Healing Trajectory agent tells you what's about to happen — and that changes the clinical decision.

The problem it solves

A diabetic foot ulcer that isn't progressing at week four rarely heals on the current plan. But without longitudinal analytics, most clinicians only recognize the stall in retrospect — after two or three more visits of the same treatment. That's lost time, wasted supplies, and higher amputation risk.

What the agent actually does

  • Ingests every measurement from the AI-powered wound imaging agent (length, width, depth, area, volume)
  • Compares wound-area trajectory against expected healing curves for the wound type and etiology
  • Classifies each wound as healing, stalling, or worsening
  • Surfaces the classification on the Healing dashboard at a glance across your entire panel

How stalling is defined

A wound that fails to achieve roughly 50% area reduction in four weeks is a well-established predictor of non-healing at 12 weeks — especially for diabetic foot ulcers. The trajectory agent uses that signal plus tissue and exudate trends from the scribed note to flag stalls early.

What you do with the signal

When a wound is flagged stalling, the decision changes: escalate debridement, reassess offloading, consider advanced therapies, or refer. See Diabetic foot care for the specific escalation pathways WoundScribe supports.

Why this is the leap

Every other agent — imaging, scribing, coding, charting, patient education — makes the encounter faster. The trajectory agent makes the encounter smarter. That's the difference between a faster horse and a car.